Which are new drugs approved this 1st quarter?

Published: 2018-04-16 16:28:00
Updated: 2018-04-16 17:05:06

4 new drugs including ‘Aljaview Inj,’ a FutureChem’s diagnostic drug for Alzheimer’s disease, reportedly acquire approval in the last 1st quarter.

According to the Ministry of Food and Drug Safety’s Online Drug Library, 4 new drugs and 2 orphan drugs acquired approval in the 1st quarter.

1 of t...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.